Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT
- PMID: 25391305
- DOI: 10.1212/WNL.0000000000001050
Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT
Abstract
Objective: We investigated the effects of 2-year folic acid and vitamin B12 supplementation on cognitive performance in elderly people with elevated homocysteine (Hcy) levels.
Methods: This multicenter, double-blind, randomized, placebo-controlled trial included 2,919 elderly participants (65 years and older) with Hcy levels between 12 and 50 µmol/L. Participants received daily either a tablet with 400 µg folic acid and 500 µg vitamin B12 (B-vitamin group) or a placebo tablet. Both tablets contained 15 µg vitamin D3. Data were available for global cognitive functioning assessed by Mini-Mental State Examination (n = 2,556), episodic memory (n = 2,467), attention and working memory (n = 759), information processing speed (n = 731), and executive function (n = 721).
Results: Mean age was 74.1 (SD 6.5) years. Hcy concentrations decreased 5.0 (95% confidence interval -5.3 to -4.7) µmol/L in the B-vitamin group and 1.3 (-1.6 to -0.9) µmol/L in the placebo group. Cognitive domain scores did not differ over time between the 2 groups, as determined by analysis of covariance. Mini-Mental State Examination score decreased with 0.1 (-0.2 to 0.0) in the B-vitamin group and 0.3 (-0.4 to -0.2) in the placebo group (p = 0.05), as determined by an independent t test.
Conclusions: Two-year folic acid and vitamin B12 supplementation did not beneficially affect performance on 4 cognitive domains in elderly people with elevated Hcy levels. It may slightly slow the rate of decline of global cognition, but the reported small difference may be attributable to chance.
Classification of evidence: This study provides Class I evidence that 2-year supplementation with folic acid and vitamin B12 in hyperhomocysteinemic elderly people does not affect cognitive performance.
© 2014 American Academy of Neurology.
Similar articles
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2 PMID: 14584018 Updated. Review.
-
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.Int J Geriatr Psychiatry. 2012 Jun;27(6):592-600. doi: 10.1002/gps.2758. Epub 2011 Jul 21. Int J Geriatr Psychiatry. 2012. PMID: 21780182 Clinical Trial.
-
Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843658 Review.
-
Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial.Am J Clin Nutr. 2006 Aug;84(2):361-70. doi: 10.1093/ajcn/84.1.361. Am J Clin Nutr. 2006. PMID: 16895884 Clinical Trial.
-
Effects of Two-Year Vitamin B12 and Folic Acid Supplementation on Depressive Symptoms and Quality of Life in Older Adults with Elevated Homocysteine Concentrations: Additional Results from the B-PROOF Study, an RCT.Nutrients. 2016 Nov 23;8(11):748. doi: 10.3390/nu8110748. Nutrients. 2016. PMID: 27886078 Free PMC article. Clinical Trial.
Cited by
-
Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression.Nutrients. 2021 Mar 12;13(3):923. doi: 10.3390/nu13030923. Nutrients. 2021. PMID: 33809274 Free PMC article.
-
Comparative assessment of methylcobalamin and ascorbic acid on cognitive function in post-menopausal women - A randomized, double-blind trial.Contemp Clin Trials Commun. 2017 Oct 16;8:175-180. doi: 10.1016/j.conctc.2017.10.006. eCollection 2017 Dec. Contemp Clin Trials Commun. 2017. PMID: 29696207 Free PMC article.
-
Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.Medicine (Baltimore). 2015 Jul;94(28):e1192. doi: 10.1097/MD.0000000000001192. Medicine (Baltimore). 2015. PMID: 26181568 Free PMC article.
-
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.Cochrane Database Syst Rev. 2018 Nov 1;11(11):CD011905. doi: 10.1002/14651858.CD011905.pub2. Cochrane Database Syst Rev. 2018. PMID: 30383288 Free PMC article.
-
Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements.Int J Mol Sci. 2020 Mar 13;21(6):1974. doi: 10.3390/ijms21061974. Int J Mol Sci. 2020. PMID: 32183152 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials